Orexo AB has announced positive data from a pre-clinical in vivo study on the nasal absorption of atipamezole when delivered with Orexo’s AmorphOX® drug delivery technology. The study...

MEKanistic Therapeutics, a biotechnology company developing first-in-class precision medicines designed to overcome cancer resistance mechanisms, has announced that the US Food and Drug Administration...

Matter Bio has submitted its first Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for Lm-LLO-TT, the company’s lead therapeutic candidate,...